Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential-Reference-Cited by-同舟云学术

Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential

Published:2022-07-25 Issue:15 Volume:65 Page:10133-10160
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zhang Jifa¹²,Zhang Lele¹²,Wang Jiaxing³,Ouyang Liang¹²^ORCID,Wang Yuxi¹²^ORCID

Affiliation:

1. Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Joint Research Institution of Altitude Health, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China

2. State Key Laboratory of Biotherapy and Cancer Center, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China

3. Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis 38163, Tennessee, United States

Funder

Natural Science Foundation of Sichuan Province

National Natural Science Foundation of China

National Major Scientific and Technological Special Project for Significant New Drugs Development

Sichuan Science and Technology Program

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00614